Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells.
about
Oxidative Stress during HIV Infection: Mechanisms and ConsequencesAbbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblastsEfavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND).N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine.The impact of HIV-1 on neurogenesis: implications for HANDCirculating brain microvascular endothelial cells (cBMECs) as potential biomarkers of the blood-brain barrier disorders caused by microbial and non-microbial factors.Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators.Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation.Alpha7 nicotinic acetylcholine receptor is required for blood-brain barrier injury-related CNS disorders caused by Cryptococcus neoformans and HIV-1 associated comorbidity factorsDysregulation of Endoplasmic Reticulum Stress and Autophagic Responses by the Antiretroviral Drug Efavirenz.Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients.HIV-1, reactive oxygen species, and vascular complicationsAntioxidant sestrin-2 redistribution to neuronal soma in human immunodeficiency virus-associated neurocognitive disorders.Human and mouse brain-derived endothelial cells require high levels of growth factors medium for their isolation, in vitro maintenance and survivalAn investigation of the effects of antiretroviral central nervous system penetration effectiveness on procedural learning in HIV+ drug usersAlpha7 nicotinic acetylcholine receptor is required for amyloid pathology in brain endothelial cells induced by Glycoprotein 120, methamphetamine and nicotine.Role of oxidative stress in infectious diseases. A review.Executive Dyscontrol of Learning and Memory: Findings from a Clade C HIV-positive South African Sample.An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?Hyperglycemia exacerbates antiretroviral drug combination induced blood-brain barrier endothelial toxicity.Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics.The potential toxicological insights about the anti-HIV drug azidothymidine-derived monoselenides in human leukocytes: Toxicological insights of new selenium-azidothymidine analogs.Premature and accelerated aging: HIV or HAART?Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals.Naringin improves zidovudine- and stavudine-induced skeletal muscle complications in rats.Mitochondrial and Oxidative Stress Response in HepG2 Cells Following Acute and Prolonged Exposure to Antiretroviral Drugs.Beyond the polymerase-γ theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity.Isolation and expansion of human and mouse brain microvascular endothelial cells.
P2860
Q28077167-7643BFB3-34C6-46DA-B231-5884A0933CFCQ28544452-044A3C7B-98BC-42F6-94BE-1DC4A3280E81Q31159582-6B1CB298-AFC8-45DC-BC91-9CAF07539DE1Q34331878-0DFF5C79-3E1A-4A43-9169-8D435EFAE550Q34472345-FD509862-F4B7-4FB9-8043-BCBEE21393CEQ34701013-783286C1-06DC-4C57-B8E0-A938365B1BE6Q35022972-0059C868-AA1A-433E-B30D-CC663CE5D7ECQ35625941-7AFCEF6A-ADB0-4B63-8776-8CF3F9C55141Q35749135-A54668A9-D093-4698-81B2-C975AD620F19Q35897840-293C3507-00C3-4033-BADF-D7E1EC5BEF35Q35998367-7B1FF382-9EB7-450D-B2CC-95242E42BC3EQ36040759-0E678E63-3A11-47BA-86E2-37D38FE8590CQ36613921-51E073D9-78E2-43A3-835F-F81265853A24Q36880688-63256305-CADF-4234-A7DA-2BE2E8CE373CQ37375961-FB02318D-49F8-4A9B-AA74-C81B74D20E9DQ37578762-FA06E47A-A9D9-4360-A487-4D9D1BAB97F5Q38090568-649F3BF9-7C2F-46B5-959A-7525C4F51CA9Q38400463-DDBFFA49-61CC-4EC5-8B99-54230DE11238Q38628801-006F5BC7-8969-4359-AD22-855E2C1D49E6Q38762179-BCD7909D-F6C0-4B9C-B72E-F6210EB1B2BFQ38816544-FB008BE5-0F11-4BF3-AF8D-AB4DEC9D809AQ38882614-96B3EAEE-4E25-4CDE-8555-055A1DAF8AABQ39253034-CAD98AEA-206B-4AD1-BCE9-A66875065804Q39474417-C5FFC0B5-2EEA-4AFA-902D-AEED73B5CF40Q40267454-5532E525-45DC-4965-B269-6BC4C2F334A3Q40744532-7C7C8257-B262-49D7-A401-5AA5E6276E82Q41293914-543CE31B-055D-4606-99B0-8182847A9E7DQ44797235-47EC3728-2C94-4C34-AE86-C3A64E16B12EQ46777341-DD25D4D1-5F26-497B-9B15-7D5A5891D152
P2860
Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Highly active antiretroviral t ...... ain barrier endothelial cells.
@en
Highly active antiretroviral t ...... ain barrier endothelial cells.
@nl
type
label
Highly active antiretroviral t ...... ain barrier endothelial cells.
@en
Highly active antiretroviral t ...... ain barrier endothelial cells.
@nl
prefLabel
Highly active antiretroviral t ...... ain barrier endothelial cells.
@en
Highly active antiretroviral t ...... ain barrier endothelial cells.
@nl
P2093
P2860
P921
P1476
Highly active antiretroviral t ...... ain barrier endothelial cells.
@en
P2093
Atrayee Banerjee
Kalyan Reddy Manda
Nuran Ercal
P2860
P304
P356
10.1016/J.FREERADBIOMED.2010.12.029
P577
2010-12-28T00:00:00Z